文献速递头颈神经MR

头颈部鳞状细胞癌的精准扩散加权成像

Precision Diffusion-Weighted Imaging of Head and Neck Squamous Cell Carcinoma.
PubMed 文献 · AJNR Am J Neuroradiol · 2026-03-04

研究优化头颈部DWI序列并确定ADC可重复性指标,26例活检证实的头颈部鳞状细胞癌患者治疗前接受同一设备重复DWI扫描,46个肿瘤区域纳入分析,重复性系数14.4%,ICC 0.8-0.83,支持优化DWI方案用于ADC定量。

要点

  • 优化DWI方案采用QIBA推荐参数、b值2000、Zoom-IT技术和聚乙烯吡咯烷酮体模校准。
  • 重复扫描ADC偏倚小,wCV 5.2-5.4%,重复性系数14.4%,ICC 0.8-0.83。
  • 两位专家手动分割Dice评分测试0.991、重测0.976,分割一致性极好。

核心结论

  • 优化DWI方案用于头颈部鳞状细胞癌ADC定量准确且可重复,重复性系数与QIBA乳腺、肝脏、前列腺体部模版相当或更优,但不及脑部模版。

研究设计与样本

  • 前瞻性研究,26例活检证实的头颈部鳞状细胞癌患者,治疗前在Siemens 3T Vida MRI扫描仪上行「咖啡休息」测试-重测DWI扫描,51个肿瘤区域中46个纳入分析,参考标准为活检病理。

诊断标准与关键数值

  • Bland-Altman图显示测试-重测ADC值偏倚极小;wCV 5.2-5.4%,重复性系数14.4%;测试-重测ICC 0.8-0.83;两位专家分割Dice评分测试0.991、重测0.976。

临床应用与阅片要点

  • 作者认为优化DWI方案可用于头颈部鳞状细胞癌ADC定量,帮助临床医生区分真实生理变化与测量误差;需进一步开展定量影像生物标志物Stage 2型研究以优化成像参数、改进可重复性标志物并确立DWI作为评估头颈部鳞状细胞癌肿瘤复发的临床标准。

局限性

  • 原文结论指出需进一步开展定量影像生物标志物Stage 2型研究以优化成像参数、改进可重复性标志物并确立DWI作为评估头颈部鳞状细胞癌肿瘤复发的临床标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Head and neck squamous cell carcinoma (HNSCC) represents a serious global health burden, with over 890,000 new cases annually and approximately 450,000 related deaths worldwide. Our study aims to optimize DWI sequences for the head and neck and determine reproducibility metrics values for ADC, allowing clinicians to distinguish between genuine physiologic changes and measurement errors.

MATERIALS AND METHODS: We optimized the head and neck DWI protocol using Qualitative Initiative Biomarker Alliance (QIBA)-recommended parameters, high 2000 b-value, Zoom-IT technology, and a polyvinylpyrrolidone phantom calibration. Twenty-six biopsy-proved patients with HNSCC underwent pretreatment "coffee-break" test-retest DWI scans on a Siemens 3T Vida MRI scanner. ADC values were extracted from 46/51 segmented tumor regions (either tumor mass or metastatic lymphadenopathy), and reproducibility measures were assessed using the within-subject coefficient of variation (wCV), repeatability coefficient, and intraclass correlation coefficient (ICC). Bland-Altman plots and correlation analyses were used to evaluate measurement precision. Both manual segmentation by 2 expert neuroradiologists and semiautomated methods of segmentation were utilized.

RESULTS: Out of 51 identified tumor masses, 46 were included in the final analysis. The Bland-Altman plot revealed minimal bias in ADC values between test-retest scans. The calculated 5.2-5.4% wCV resulted in a repeatability coefficient of 14.4%. The ICC between test and retest measurements was 0.8-0.83, indicating good test-retest reliability. The Dice score between the 2 expert readers for all parameters indicated excellent agreement between segmentations performed by different readers, with values of 0.991 for the test measurement and 0.976 for the retest measurement.

CONCLUSIONS: Our findings support the use of an optimized DWI protocol for accurate and reproducible ADC quantification in HNSCC, which is comparable with or better than the percent repeatability coefficient derived from QIBA profiles for breast, liver, and prostate, though it is inferior to those for the brain. Further quantitative imaging biomarker Stage 2-type profile research is necessary to refine imaging parameters, improve reproducibility markers, and establish DWI as a clinical standard for evaluating HNSCC tumor recurrence.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Guzmán Pérez-Carrillo GJ, Wang W, Liu J, et al. Precision Diffusion-Weighted Imaging of Head and Neck Squamous Cell Carcinoma. AJNR Am J Neuroradiol. 2026. PMID: 41022563. doi:10.3174/ajnr.A9026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。